Interactions between toll‐like receptors signaling pathway and gut microbiota in host homeostasis

Author:

Chen Luping12ORCID,Zhang Linfang13,Hua Hua45,Liu Li45,Mao Yuejian6,Wang Ruirui1ORCID

Affiliation:

1. Shanghai Innovation Center of TCM Health Service Shanghai University of Traditional Chinese Medicine Shanghai China

2. Department of Pharmacology and Toxicology, School of Nutrition and Translational Research in Metabolism Maastricht University Maastricht The Netherlands

3. Oxford Suzhou Centre for Advanced Research Suzhou China

4. Sichuan Institute for Translational Chinese Medicine Chengdu China

5. Sichuan Academy of Chinese Medical Sciences Chengdu China

6. Global R&D Innovation Center Inner Mongolia Mengniu Dairy (Group) Co. Ltd. Hohhot Inner Mongolia China

Abstract

AbstractBackgroundToll‐like receptors (TLRs) are a family of fundamental pattern recognition receptors in the innate immune system, constituting the first line of defense against endogenous and exogenous antigens. The gut microbiota, a collection of commensal microorganisms in the intestine, is a major source of exogenous antigens. The components and metabolites of the gut microbiota interact with specific TLRs to contribute to whole‐body immune and metabolic homeostasis.ObjectiveThis review aims to summarize the interaction between the gut microbiota and TLR signaling pathways and to enumerate the role of microbiota dysbiosis‐induced TLR signaling pathways in obesity, inflammatory bowel disease (IBD), and colorectal cancer (CRC).ResultsThrough the recognition of TLRs, the microbiota facilitates the development of both the innate and adaptive immune systems, while the immune system monitors dynamic changes in the commensal bacteria to maintain the balance of the host‐microorganism symbiosis. Dysbiosis of the gut microbiota can induce a cascade of inflammatory and metabolic responses mediated by TLR signaling pathways, potentially resulting in various metabolic and inflammatory diseases.ConclusionUnderstanding the crosstalk between TLRs and the gut microbiota contributes to potential therapeutic applications in related diseases, offering new avenues for treatment strategies in conditions like obesity, IBD, and CRC.

Funder

National Natural Science Foundation of China

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3